[1]府裕琦 吕娟丽 陈熙 吕红梅 杨小强 赵颖波.基于全国抗菌药物临床应用监测网的手术组病例用药合理性分析[J].中国卫生质量管理,2024,31(04):001-6.[doi:10.13912/j.cnki.chqm.2024.31.4.01]
　FU Yuqi,LV Juanli,CHEN Xi,et al.Analysis of the Rationality of Drug Use in the Surgical Group Based on the Center for Antibacterial Surveillance[J].Chinese Health Quality Management,2024,31(04):001-6.[doi:10.13912/j.cnki.chqm.2024.31.4.01]
点击复制

基于全国抗菌药物临床应用监测网的手术组病例用药合理性分析()
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第31卷
期数:
2024年04期
页码:
001-6
栏目:
特别关注
出版日期:
2024-04-15

文章信息/Info

Title:
Analysis of the Rationality of Drug Use in the Surgical Group Based on the Center for Antibacterial Surveillance
作者:
府裕琦 吕娟丽 陈熙 吕红梅 杨小强 赵颖波
国家卫生健康委医院管理研究所
Author(s):
FU Yuqi; LV Juanli; CHEN Xi; et al
National Institute of Hospital Administration,National Health Commission
关键词:
抗菌药物; 合理用药; 用药评价; 围手术期; 监测
Keywords:
Antibiotics;  Rational Drug-Use Evaluation;  Perioperative Period;  Monitoring
分类号:
R197
DOI:
10.13912/j.cnki.chqm.2024.31.4.01
文献标志码:
A
摘要:
目的分析全国抗菌药物临床应用监测网中手术组病例用药的合理性。方法通过建立抗菌药物临床应用监测网病例评价标准，对手术组病例抗菌药物使用的合理性进行评价。结果我国手术组病例预防用抗菌药物使用率呈下降趋势，2021年I类切口手术预防用抗菌药物的使用率为32.20%，无适应证用药的比例从2017年的11.35%下降到2021年的6.87%，抗菌药物预防使用的合理率从2017年的15.05%上升到2021年的29.73%。不合理用药情况主要表现为围手术期用药不合理，构成比5年均值为55.13%；其次为药物选择不合理，构成比5年均值为18.58%；以及每日给药次数、单次剂量不合理等。结论需持续加强手术抗菌药物使用管理和监测力度，保障临床用药安全。
Abstract:
ObjectiveTo analyze the rationality of clinical application of antibiotics in the surgical group based on the Center for Antibacterial Surveillance in China.MethodsThe reasonableness of the use of antibiotics in the surgical group was evaluated by establishing the case evaluation criteria of the Center for Antibacterial Surveillance.ResultsThe use of preventive antibiotics in the surgical group showed a decreasing trend.In 2021, the use of preventive antibiotics in Class I incision surgery was 32.20%, and the rate of use without indication decreased from 11.35% in 2017 to 6.87% in 2021. The Rationalization rate of antibiotics use increased from 15.05% in 2017 to 29.73% in 2021. Irrational use of drugs was mainly due to Irrational drugs use in the perioperative period,with an average composition ratio of 55.13% in 5 years, followed by irrational medications selection,with an average composition ratio of 18.58% in 5 years, and unreasonable daily administration times and single dose.Conclusion It is necessary to strengthen the management and monitoring of antibiotics use in surgery to ensure the safety of clinical use.

参考文献/References:

［1］卫生部办公厅,国家中医药管理局办公室,总后卫生部. 关于建立抗菌药物临床应用及细菌耐药监测网的通知：国办医发〔2005〕176号［EB/OL］.(2005-11-29)［2023-04-17］. http://www.nhc.gov.cn/zwgkzt/pyzgl1/200804/18487.shtml.［2］国家卫生计生委办公厅,国家中医药管理局办公室,解放军总后勤部卫生部药品器材局.关于印发抗菌药物临床应用指导原则（2015年版）的通知:国卫办医发〔2015〕43号［EB/OL］.(2015-07-24)［2023-04-17］.http://www.nhc.gov.cn/yzygj/s3593/201508/c18e1014de6c45ed9f6f9d592b 43db42.shtml.［3］BRATZLER DW,DELLINGER EP,OLSEN KM,et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery［J］.Am J Health Syst Pharm,2013,70（3）:195-283.［4］SALM L,MARTI WR,STEKHOVEN DJ,et al.Impact of bodyweight-adjusted antimicrobial prophylaxis on surgical-site infection rates［J］.BJS Open, 2020, 5(1):1-6.［5］KOJI Y,KUNIHIRO M,FUMIAKI T,et al.Are bone and serum cefazolin concentrations adequate for antimicrobial prophylaxis?［J］.Clin Orthop Relat Res,2011,469(12):3486-3494.［6］CHEN PJ, HUA YM, HAN ST,et al.Topical antibiotic prophylaxis for surgical wound infections in clean and clean-contaminated surgery: a systematic review and meta-analysis［J］.BJS Open, 2021,125:1-12.［7］DEPCINSKI SC,NGUYEN KH,ENDER PT.Cefazolin and an aminoglycoside compared with cefazolin alone for the antimicrobial prophylaxis of type III open orthopedic fractures［J］.Int J Crit Illn Inj Sci,2019,9(3): 127-131.［8］JONGE SW,GANS SL,JASPER JA,et al.Timing of preoperative antibiotic prophylaxis in 54 552 patients and the risk of surgical site infection a systematic review and meta-analysis［J］.Medicine,2017,96(29):1-12.［9］STECCANELLA F,AMORETTI P,BARBIERI MR,et al. Antibiotic prophylaxis for hepato-biliopancreatic surgery—a systematic review［J］.Antibiotics,2022,11(2):194.［10］World Health Organization. Global guidelines for the prevention of surgical site infection［Z］.2016.［11］BERRIOS TS, UMSCHEID CA, BRATZLER DW, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection［J］.JAMA Surg,2017,152(8):784-791.［12］MARIMUTHU C,ABRAHAM V T,RAVICHANDRAN M,et al.Antimicrobial prophylaxis in instrumented spinal fusion surgery: a comparative analysis of 24-hour and 72-hour dosages［J］.Asian Spine J,2016,10(6):1018-1022.

相似文献/References:

[1]王凯 顾嘉钦 朱珺 侯旭敏.精细化管理促进辅助药物合理使用[J].中国卫生质量管理,2019,26(03):054.[doi:10.13912/j.cnki.chqm.2019.26.3.16]
[2]赵娴 张青 鹿秀丽 王雨来.基于HIMSS EMRAM 7 标准的合理用药系统建立与应用[J].中国卫生质量管理,2019,26(03):090.[doi:10.13912/j.cnki.chqm.2019.26.3.25]
[3]余雄杰 张静 匡玉霞 陈锦华.应用SAP平台加强抗菌药物临床应用管理[J].中国卫生质量管理,2020,27(02):084.[doi:10.13912/j.cnki.chqm.2020.27.2.26]
[4]王栋罗平刘韶尹桃龚志成.住院患者静脉输液专项管理实践[J].中国卫生质量管理,2022,29(05):034.[doi:10.13912/j.cnki.chqm.2022.29.5.09 ]
　WANG Dong,LUO Ping,LIU Shao.Special Management Practice of Intravenous Infusion for Inpatients[J].Chinese Health Quality Management,2022,29(04):034.[doi:10.13912/j.cnki.chqm.2022.29.5.09 ]
[5]邓明林伟龙时黎明杨谨成安宇杨娟周成诚杨文静.北京市79家医院抗肿瘤药物规范使用现状与影响因素分析[J].中国卫生质量管理,2022,29(11):021.[doi:10.13912/j.cnki.chqm.2022.29.11.06 ]
　DENG Ming,LIN Weilong,SHI Liming.Current Status and Influencing Factors of Standardized Use of Antitumor Drugs in 79 Hospitals in Beijing[J].Chinese Health Quality Management,2022,29(04):021.[doi:10.13912/j.cnki.chqm.2022.29.11.06 ]
[6]李娜马丽平孙晓宇杨威刘倩楠熊康吴奇飞.试点医院抗菌药物管理体系建设与评价[J].中国卫生质量管理,2022,29(12):034.[doi:10.13912/j.cnki.chqm.2022.29.12.08 ]
　LI Na,MA Liping,SUN Xiaoyu.Construction and Evaluation of Antimicrobial Stewardship in Experimental Hospitals[J].Chinese Health Quality Management,2022,29(04):034.[doi:10.13912/j.cnki.chqm.2022.29.12.08 ]
[7]郑婷婷李锦卞婧张威甄健存.以合理用药绩效管理促进医院高质量发展[J].中国卫生质量管理,2022,29(12):047.[doi:10.13912/j.cnki.chqm.2022.29.12.11 ]
　ZHENG Tingting,LI Jin,BIAN Jing.To Promote the High Quality Development of Hospitals by Performance Management of Rational Drug Use[J].Chinese Health Quality Management,2022,29(04):047.[doi:10.13912/j.cnki.chqm.2022.29.12.11 ]
[8]魏伟赵新才张剑萍徐桔密刘杰曹建文郭澄.基于SPO理论的医院抗菌药物管理体系应用探讨[J].中国卫生质量管理,2024,31(03):028.[doi:10.13912/j.cnki.chqm.2024.31.3.08]
　WEI Wei,ZHAO Xincai,ZHANG Jianping.Application of Antibiotics Management System in Hospital Based on SPO Theory[J].Chinese Health Quality Management,2024,31(04):028.[doi:10.13912/j.cnki.chqm.2024.31.3.08]
[9]陈熙 府裕琦 吕红梅 赵颖波.我国医疗机构患者自备输注药品管理现状调查分析[J].中国卫生质量管理,2024,31(04):011.[doi:10.13912/j.cnki.chqm.2024.31.4.03]
　CHEN Xi,FU Yuqi,LV Hongmei,et al.Investigation and Analysis of Management Status about Patient Self-Provided Infusion Drugs in Medical Institutions in China[J].Chinese Health Quality Management,2024,31(04):011.[doi:10.13912/j.cnki.chqm.2024.31.4.03]

更新日期/Last Update: 2024-04-15